M. Jachym

Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort

Lorenzo Guglielmetti, D. Le Dû, M. Jachym et al. · Clinical Infectious Diseases · 2014 · 186 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis

Lorenzo Guglielmetti, Marie Jaspard, Damien Le Dû et al. · European Respiratory Journal · 2016 · 155 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Target regimen profiles for tuberculosis treatment

Christian Lienhardt, Kelly E. Dooley, Payam Nahid et al. · Bulletin of the World Health Organization · 2024 · 25 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacology +17

Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment

Johannes Eimer, M. Jachym, Damien Le Dû et al. · Clinical Infectious Diseases · 2022 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +17

Isoniazid-monoresistant tuberculosis in France: Risk factors, treatment outcomes and adverse events

Marwa Bachir, Lorenzo Guglielmetti, Simone Tunesi et al. · International Journal of Infectious Diseases · 2021 · 20 citations · Full text

Public Health, Pharmacotherapy, Clinical Epidemiology +14